Modern prostate cancer diagnostics reduce overdiagnosis - will they open up for population-based screening?

Scand J Urol. 2021 Dec;55(6):491-492. doi: 10.1080/21681805.2021.1980608. Epub 2021 Oct 4.

Authors

Ola Bratt¹, Hans Lilja^{2

3}

Affiliations

¹ Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Departments of Laboratory Medicine, Surgery (Urology Service), and Medicine (GU-Oncology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Translational Medicine, Lund University, Malmö, Sweden.

PMID: 34605720
DOI: 10.1080/21681805.2021.1980608

No abstract available

Publication types

News

MeSH terms

Early Detection of Cancer
Humans
Male
Overdiagnosis*
Prostate
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / epidemiology

Substances

Prostate-Specific Antigen